Loss of beta cell mass (BCM) is a hallmark of diabetes that could be potentially studied non-invasively by Positron Emission Tomography (PET). MK7246 is an antagonist of the GPR44 receptor (also called PGD2 or CRTH2) that is selectively expressed on pancreatic beta cells.